Transgenesis and gene targeting in the mouse: Tools for studying genetic determinants of hypertension

Trends in Cardiovascular Medicine

Volumn 8, Issue 6, 1998, Pages 256-264

  Stec, David E ^a   Davisson, Robin L ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; GENE PRODUCT; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ESSENTIAL HYPERTENSION; GENE OVEREXPRESSION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITARY HYPERTENSION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SHORT SURVEY; TRANSGENIC MOUSE;

EID: 0031691649     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(98)00016-4     Document Type: Article

References (76)

1. Albrecht FE, Drago J, Felder RA, et al.: 1996. Role of the D1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 97:2283-2288.
2. Borkowski JA, Hess JF: 1995. Targeted disruption of the mouse B2 bradykinin receptor in embryonic stem cells. Can J Physiol Pharmacol 73:773-779.
3. Bronson SK, Plaehn EG, Kluckman KD, et al.: 1996. Single-copy transgenic mice with chosen-site integration. Proc Natl Acad Sci USA 93:9067-9072.
4. Bronson SK, Smithies O: 1994. Altering mice by homologous recombination using embryonic stem cells. J Biol Chem 269: 27155-27158.
5. Campbell WGJ, Ganhem F, Catanzaro DF, et al.: 1996. Plasma and renal prorenin/renin, renin mRNA and blood pressure in Dahl S and R rats. Hypertension 27:1121-1133.
6. Caulfield M, Lavender P, Farrall M, et al.: 1994. Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629-1633.
7. Cavalli A, Lattion AL, Hummler E, et al.: 1997. Decreased blood pressure response in mice deficient of the alpha1b-adrenergic receptor. Proc Natl Acad Sci USA 94:11589-11594.
8. Chao J, Chao L: 1996. Functional analysis of human tissue kallikrein in transgenic mouse models. Hypertension 27:491-494.
9. Chen XM, Li WG, Yoshida H, et al.: 1997. Targeting deletion of angiotensin type 1B receptor gene in the mouse. Am J Physiol 41:F299-F304.
10. Clark AF, Sharp MF, Morley SD, et al.: 1997. Renin-1 is essential for normal renal juxtaglomerular cell granulation and macula densa morphology. J Biol Chem 272: 18185-18190.
11. Davisson RL, Beltz TG, Merrill DC, Johnson AK, Sigmund CD: 1997a. The brain renin-angiotensin system contributes to the hypertension exhibited by mice containing both human renin and human angiotensinogen transgenes via an angiotensin II/ vasopressinergic mechanism [abst]. Hypertension 30:471.
12. Davisson RL, Kim HS, Krege JH, et al.: 1997b. Complementation of reduced survival, hypotension and renal abnormalities in angiotensinogen deficient mice by the human renin and human angiotensinogen genes. J Clin Invest 99:1258-1264.
13. Ding Y, Davisson RL, Hardy DO, et al.: 1997a. Inducible hypertension due to selective activation of an intrinsic intra-renal renin-angiotensin system in transgenic mice [abst]. Hypertension 30:480.
14. Ding Y, Davisson RL, Hardy DO, et al.: 1997b. The kidney androgen-regulated protein (KAP) promoter confers renal proximal tubule cell-specific and highly androgen-responsive expression on the human angiotensinogen gene in transgenic mice. J Biol Chem 272:28142-28148.
15. Esther CR Jr, Howard TE, Marino EM, et al.: 1996. Mice lacking angiotensin-converting enzyme have low blood pressure, renal pathology, and reduced male fertility. Lab Invest 74:953-965.
16. Field LJ, Veress AT, Steinhelper ME, Cochrane K, Sonnenberg H: 1991. Kidney function in ANF-transgenic mice: effect of blood volume expansion. Am J Physiol 260: R1-R5.
17. Fornage M, Turner ST, Sing CF, Boerwinkle E: 1995. Variation at the M235T locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genetics 96:295-300.
18. Fukamizu A, Sugimura K, Takimoto E, et al.: 1993. Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J Biol Chem 268:11617-11621.
19. Furth PA, St Onge L, Böger H, et al.: 1994. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 91: 9302-9306.
20. Ganten D, Lindpaintner K, Ganten U, et al.: 1991. Transgenic rats: new animal models in hypertension research. Hypertension 17: 843-855.
21. Gu H, Marth JD, Orban PC, Mossman H, Rajewsky K: 1994. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science 265: 103-106.
22. Hatae T, Takimoto E, Murakami K, Fukamizu A: 1994. Comparative studies on species-specific reactivity between renin and angiotensinogen. Mol Cell Biochem 131:43-47.
23. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK: 1995. Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377:744-747.
24. Hocher B, Thone-Reineke C, Rohmeiss P, et al.: 1997. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension. J Clin Invest 99:1380-1389.
25. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC: 1993. Targeted disruption of the neuronal nitric oxide synthase gene. Cell 75:1273-1286.
26. Huang PL, Huang ZH, Mashimo H, et al.: 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 377:239-242.
27. Ichiki T, Labosky PA, Shiota C, et al.: 1995. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748-750.
28. Inoue I, Nakajima T, Williams CS, et al.: 1997. A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797.
29. Ito M, Oliverio MI, Mannon PJ, et al.: 1995. Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 92:3521-3525.
30. Jacob HJ, Lindpaintner K, Lincoln SE, et al.: 1991. Genetic mapping of a gene causing hypertension in the stroke-prone spontaneously hypertensive rat. Cell 67:213-224.
31. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al.: 1992. Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180.
32. John SWM, Krege JH, Oliver PM, et al.: 1995. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension. Science 267:679-681.
33. Kim HS, Krege JH, Kluckman KD, et al.: 1995. Genetic control of blood pressure and the angiotensinogen locus. Proc Natl Acad Sci USA 92:2735-2739.
34. Kimura S, Mullins JJ, Bunnemann B, et al.: 1992. High blood pressure in transgenic mice carrying the rat angiotensinogen gene. EMBO J 11:821-827.
35. Krege JH: 1996. Mouse systems for studying the genetics of hypertension and related disorders. Trends Cardiovasc Med 6:232-238.
36. Krege JH, John SWM, Langenbach LL, et al.: 1995. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 375:146-148.
37. Kuhn R, Schwenk F, Aguet M, Rajewsky K: 1995. Inducible gene targeting in mice. Science 269:1427-1429.
38. Kurihara Y, Kurihara H, Suzuki H, et al.: 1994. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368:703-710.
39. Kuro-o M, Hanaoka K, Hiroi Y, et al.: 1995. Salt-sensitive hypertension in transgenic mice overexpressing Na(+)-proton exchanger. Circ Res 76:148-153.
40. Laubach VE, Shesely EG, Smithies O, Sherman PA: 1995. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 92:10688-10692.
41. Ledent C, Vaugeois JM, Schiffmann SN, et al.: 1997. Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor. Nature 388:674-678.
42. Lee MA, Böhm M, Paul M, et al.: 1996. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol 270:E919-E929.
43. Lifton RP, Dluhy RG, Powers M, et al.: 1992. A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262-265.
44. Link RE, Stevens MS, Kulatunga M, Scheinin M, Barsh GS, Kobilka BK: 1995. Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog. Mol Pharmacol 48:48-55.
45. Link RE, Desai K, Hein L, et al.: 1996. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 273:803-805.
46. Lopez MJ, Wong SKF, Kishimoto I, et al.: 1995. Salt-resistant hypertension in mice lacking the guanylyl cyclase: a receptor for atrial natriuretic peptide. Nature 378:65-68.
47. Meng W, Ma J, Ayata C, et al.: 1996. ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms. Am J Physiol 271:H1145-H1150.
48. Merrill DC, Thompson MW, Carney C, et al.: 1996. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes. J Clin Invest 97: 1047-1055.
49. Mullins JJ, Peters J, Ganten D: 1990. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 344:541-544.
50. Niimura F, Labosky PA, Kakuchi J, et al.: 1995. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 96:2947-2954.
51. No D, Yao TP, Evans RM: 1996. Ecdysone-inducible gene expression in mammalian cells and transgenic mice. Proc Natl Acad Sci USA 93:3346-3351.
52. Ohkubo H, Kawakami H, Kakehi Y, et al.: 1990. Generation of transgenic mice with elevated blood pressure by introduction of the rat renin and angiotensinogen genes. Proc Natl Acad Sci USA 87:5153-5157.
53. Oliverio MI, Best CF, Smithies O, Coffman TM: 1997. A severe kidney phenotype in AT1A receptor-deficient mice [abst]. J Am Soc Nephrol 8:406A.
54. Peterson KR: 1997. Production and analysis of transgenic mice containing yeast artificial chromosomes. Genet Engineering 19: 235-255.
55. Rapp JP, Wang SM, Dene H: 1989. A genetic polymorphism in the renin gene of Dahl rats cosegregates with blood pressure. Science 243:542-544.
56. Rohrer DK, Desai KH, Jasper JR, et al.: 1996. Targeted disruption of the mouse betal-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci USA 93:7375-7380.
57. Sander M, Bader M, Djavidani B, et al.: 1992. The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27. Endocrinology 131:807-814.
58. Sharp MG, Fettes D, Brooker G, et al.: 1996. Targeted inactivation of the Ren-2 gene in mice. Hypertension 28:1126-1131.
59. Shesely EG, Maeda N, Kim HS, et al.: 1996. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci USA 93:13176-13181.
60. Shimkets RA, Warnock DG, Bositis CM, et al.: 1994. Liddle's syndrome: heritable human hypertension caused by mutations in the b subunit of the epithelial sodium channel. Cell 79:407-414.
61. Smithies O, Kim H-S: 1994. Targeted gene duplication and disruption for analyzing quantitative genetic traits in mice. Proc Natl Acad Sci USA 91:3612-3615.
62. Sonnenberg H, Honrath U, Chong CK, Field LJ, Veress AT: 1994. Proximal tubular function in transgenic mice overexpressing atrial natriuretic factor. Can J Physiol Pharmacol 72:1168-1170.
63. Steinhelper ME, Cochrane KL, Field LJ: 1990. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension 16:301-307.
64. Suga S, Nakao K, Hosoda K, et al.: 1992. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 130:229-239.
65. Sugaya T, Nishimatsu S, Tanimoto K, et al.: 1995. Angiotensin II type 1a receptor-deficient mice with hypotension and hyperreninemia. J Biol Chem 270:18719-18722.
66. Takimoto E, Ishida J, Sugiyama F, et al.: 1996. Hypertension induced in pregnant mice by placental renin and maternal angiotensinogen. Science 274:995-998.
67. Tanimoto K, Sugiyama F, Goto Y, et al.: 1994. Angiotensinogen-deficient mice with hypotension. J Biol Chem 269:31334-31337.
68. Tsien JZ, Chen DF, Gerber D, et al.: 1996. Subregion- and cell type-restricted gene knockout in mouse brain. Cell 87:1317-1326.
69. Tsuchida S, Matsusaka T, Chen X, et al.: 1997. Murine double nullizygotes of the angiotensin type 1A and 1B receptor genes have the same abnormal phenotypes as angiotensinogen nullizygotes and more [abst]. J Am Soc Nephrol 8:309A.
70. Ukkola O, Savolainen MJ, Salmela PI, et al.: 1995. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene associated with macroangiopathy and blood pressure in patients with non-insulin-dependent diabetes mellitus. J Mol Med 73:307-311.
71. Veress AT, Chong CK, Field LJ, Sonnenberg H: 1995. Blood pressure and fluid-electrolyte balance in ANF-transgenic mice on high- and low-salt diets. Am J Physiol 269: R186-R192.
72. Wang DZ, Chao L, Chao J: 1997. Hypotension in transgenic mice overexpressing human bradykinin B2 receptor. Hypertension 29: 488-493.
73. Ward K, Hata A, Jeunemaitre X, et al.: 1993. A molecular variant of angiotensinogen associated with preeclampsia. Nature Genet 4:59-61.
74. Yang G, Merrill DC, Thompson MW, Robillard JE, Sigmund CD: 1994. Functional expression of the human angiotensinogen gene in transgenic mice. J Biol Chem 269: 32497-32502.
75. Yang G, Sigmund CD: 1998. Regulatory elements required for human angiotensinogen expression in HepG2 cells are dispensible in transgenic mice. Hypertension 31:734-740.
76. Yongue BG, Angulo JA, McEwen BS, Myers MM: 1991. Brain and liver angiotensinogen messenger RNA in genetic hypertensive and normotensive rats. Hypertension 17:485-491.